Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 10 matching records.
10 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Recent Advances on Extracellular Vesicles: A Natural Nanomaterial for Biomedical Application
Narrative Review, published in Biomimetics (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Biomimetics (Basel) - Level DNarrative ReviewEurope PMC
Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer
Narrative Review, published in ACS Nano (2025) — summary generated from the PubMed abstract.
- 2025
ACS Nano19 citations - Level DAnimal StudyPubMed
Synergistic Anti-Aging Effects of Adipose-Derived Stem Cell Extracellular Vesicles Loaded With Natural Compounds.
Animal Study on Skin Aging, published in J Cosmet Dermatol (2025) — summary generated from the PubMed abstract.
- 2025
J Cosmet Dermatol1 citations - Level AMeta-analysisPubMed
Nanoscale therapeutics for erectile dysfunction: a meta-analysis of stem cell-derived extracellular vesicles as natural nanoparticles in diabetic rat models.
Meta-analysis on Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level DNarrative ReviewEurope PMC
Natural and engineered extracellular vesicles in vascular diseases: a focus on therapeutic effects, challenges and prospective
Narrative Review on Face & Skin, Systemic / IV, published in Eur J Med Res (2025) — summary generated from the PubMed abstract.
- 2025
Eur J Med Res - Level DNarrative ReviewEurope PMC
The impact of natural and engineered extracellular vesicles on post-myocardial infarction angiogenesis
Narrative Review on Cardiovascular Disease, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther1 citations - Level BClinical TrialEurope PMC
Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review
Clinical Trial, published in Pharmaceutics (2023) — summary generated from the PubMed abstract.
- 2023
Pharmaceutics12 citations - Level DNarrative ReviewEurope PMC
A Powerful Tool in the Treatment of Myocardial Ischemia-Reperfusion Injury: Natural and Nanoscale Modified Small Extracellular Vesicles Derived from Mesenchymal Stem Cells
Narrative Review on Cardiovascular Disease, published in Int J Nanomedicine (2023) — summary generated from the PubMed abstract.
- 2023
Int J Nanomedicine6 citations - Level DNarrative ReviewEurope PMC
Extracellular Vesicles as Natural Delivery Carriers Regulate Oxidative Stress Under Pathological Conditions
Narrative Review, published in Front Bioeng Biotechnol (2021) — summary generated from the PubMed abstract.
- 2021
Front Bioeng Biotechnol38 citations - Level DAnimal StudyEurope PMC
Proteome Analysis of Human Natural Killer Cell Derived Extracellular Vesicles for Identification of Anticancer Effectors
Animal Study, published in Molecules (2020) — summary generated from the PubMed abstract.
- 2020
Molecules35 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406